5/8/24 - $ecor - dip buying low $6s ex post tn or nothing5/8/24 - vrockstar - weird one to write about - but revenue trends are actually solid over a pretty multi-year period. a non-"consumer" affected med-tech that's flexing opex. really hard to value on the fly, but if i conservatively say the $50 mm revenue in 2-3 yr is broadly correct at a 3x multiple